First, we show that several colon cancer cell lines, including p53 wild-type and p53 mutant/knockout human colon cancer cells, exhibit morphologic and biochemical features characteristic of cells undergoing autophagy following treatment with the DNA-damaging drug topotecan. Here, TP53 is linked to malignant colon neoplasm.